Literature DB >> 15020021

Effects of drug treatment for heroin sniffers: a protective factor against moving to injection?

Margaret S Kelley1, Dale D Chitwood.   

Abstract

We explore the relationship between contact with treatment and transition to injection for heroin sniffers. Our primary research question is, does contact with treatment delay onset of injection for heroin sniffers? A stratified network-based sample was recruited from multiple communities in South Florida which were known for high drug use. Three categories of respondents were recruited based on injection outcome: long-term injectors, short-term injectors, and sniffers (n = 900). We answer our research question in two steps. First, we investigate the prevalence of drug treatment for heroin sniffers and injectors using case-control methods. The preliminary findings indicate a positive relationship between contact with treatment and injection status outcome. Second, we further examine the relationship by attempting to identify the causal factors that delay initial injection for a subgroup of current injectors using survival regression procedures. Delaying or preventing transition to injection could significantly decrease risk of HIV transmission by reducing or eliminating risky injecting behaviors. We conclude with a discussion of policy implications and suggestions for future research.

Entities:  

Mesh:

Year:  2004        PMID: 15020021     DOI: 10.1016/j.socscimed.2003.08.006

Source DB:  PubMed          Journal:  Soc Sci Med        ISSN: 0277-9536            Impact factor:   4.634


  18 in total

1.  Drug use generations and patterns of injection drug use: Birth cohort differences among people who inject drugs in Los Angeles and San Francisco, California.

Authors:  Ricky N Bluthenthal; Lynn Wenger; Daniel Chu; Philippe Bourgois; Alex H Kral
Journal:  Drug Alcohol Depend       Date:  2017-04-19       Impact factor: 4.492

2.  Prevalence and correlates of former injection drug use among young noninjecting heroin users in Chicago.

Authors:  Dita Broz; Lawrence J Ouellet
Journal:  Subst Use Misuse       Date:  2010-10       Impact factor: 2.164

3.  Risk factors associated with the transition from heroin sniffing to heroin injection: a street addict role perspective.

Authors:  Jesús Sánchez; Dale D Chitwood; Dixie J Koo
Journal:  J Urban Health       Date:  2006-09       Impact factor: 3.671

Review 4.  Epidemiology of Injection Drug Use: New Trends and Prominent Issues.

Authors:  Élise Roy; Nelson Arruda; Julie Bruneau; Didier Jutras-Aswad
Journal:  Can J Psychiatry       Date:  2016-02-10       Impact factor: 4.356

5.  History of being in government care associated with younger age at injection initiation among a cohort of street-involved youth.

Authors:  Brittany Barker; Thomas Kerr; Huiru Dong; Evan Wood; Kora DeBeck
Journal:  Drug Alcohol Rev       Date:  2017-03-23

6.  An Exploratory Study of Inhalers and Injectors Who Used Black Tar Heroin.

Authors:  Jane Carlisle Maxwell; Richard T Spence
Journal:  J Maint Addict       Date:  2006-01-01

7.  Injecting transition risk and depression among Mexican American non-injecting heroin users.

Authors:  Alice Cepeda; Charles Kaplan; Alan Neaigus; Miguel Ángel Cano; Yolanda Villarreal; Avelardo Valdez
Journal:  Drug Alcohol Depend       Date:  2012-06-30       Impact factor: 4.492

8.  Heroin transition risk among daily and non-daily cannabis users who are non-injectors of heroin.

Authors:  Avelardo Valdez; Alice Cepeda; Alan Neaigus; Amy Russell
Journal:  Int J Drug Policy       Date:  2007-08-06

9.  Situating the Continuum of Overdose Risk in the Social Determinants of Health: A New Conceptual Framework.

Authors:  Ju Nyeong Park; Saba Rouhani; Leo Beletsky; Louise Vincent; Brendan Saloner; Susan G Sherman
Journal:  Milbank Q       Date:  2020-08-18       Impact factor: 4.911

10.  Racial and ethnic changes in heroin injection in the United States: implications for the HIV/AIDS epidemic.

Authors:  Dita Broz; Lawrence J Ouellet
Journal:  Drug Alcohol Depend       Date:  2008-02-01       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.